✦ LIBER ✦

PCN96 A TRIAL-BASED ASSESSMENT OF THE COST-UTILITY OF BEVACIZUMAB AND CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

✍ Scribed by B Goulart; S Ramsey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Utility of the chemotherapy in advanced

✍ Souquet, P.J.; Boissel, J.P.; Bernard, J.P. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Patterns, costs and cost-effectiveness o

✍ Billingham, L.J; Bathers, S; Burton, A; Bryan, S; Cullen, M.H 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 161 KB

A data-based meta-analysis of randomised

✍ Souhami, R.L.; Stewart, L.A.; Arriagada, R.; Parmar, M.; Le Chevalier, T.; Pigno 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Single-agent versus combination chemothe

✍ R. Lilenbaum; J. Herndon; M. List; C. Desch; D. Watson; J. Holland; J. Weeks; M. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 328 KB

9135 POSTER Immune-modulating Effects of

✍ Bestoso, E.; Botta, C.; Apollinari, S.; Giorgi, G.; Cusi, M.G.; Correale, P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Phase I trials of taxol-containing chemo

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 180 KB